Bis-imidazolinylindoles are active against methicillin-resistant Staphylococcus aureus and multidrug-resistant Mycobacterium tuberculosis

  • J Antibiot (Tokyo). 2013 Jan;66(1):47-9. doi: 10.1038/ja.2012.93.
Rekha G Panchal  1 ,  Douglas Lane ,  Helena I Boshoff ,  Michelle M Butler ,  Donald T Moir ,  Terry L Bowlin ,  Sina Bavari
Affiliations
  • 1. Target Discovery and Experimental Microbiology Department, United States Army Medical Research Institute of Infectious Diseases, Frederick, MD, USA. [email protected]
PMID: 23149517 DOI: 10.1038/ja.2012.93
Products